China / National Reimbursement Drug List (NRDL) 2020: What Reward for Innovation?
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
innovation
Singapore / Building a Globally Competitive Innovation Ecosystem
Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest some USD 20 billion over the next 5 years. Here, three key stakeholders from…
China / Roche Hoping to Spearhead ‘Created in China’ Push with New Innovation Accelerator
In May 2021 Swiss giant Roche launched the ‘Roche Accelerator’ in Shanghai, a USD 31.1 million investment…
Europe / Will New Pharmaceutical Strategy Prove to be a Game-Changer?
On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of…
In Conversation
Erik W. Jakobsen – Partner & Co-Founder, Menon Economics, Norway
Erik W. Jakobsen of Norwegian consultancy Menon Economics gives an overview of the key dynamics at play in Norway’s economy today and the growing role that healthcare and the life sciences plays within it. Jakobsen touches on why Norway needs to become more competitive as a life sciences investment destination, the challenges of scaling-up and commercialising Norwegian innovation, and why…
USA / Pharma Innovation Factsheet 2020
In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US…
Related Report
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
Colombia / $25 million US Cannabis Deal; COVID-Related Consumer Health Boom; Bayer Prioritises Innovation
The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated…
Opinion / Maintaining Open Innovation in Our ‘New Normal’ Through Virtual Collaboration
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park explores new ways of virtual collaboration that…
China / National Reimbursement Drug List (NRDL) 2020: What Reward for Innovation?
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
Tattoo Sensor Technology: The Future of Maltese Innovation?
UMANA T1 – a patient monitoring ecosystem that uses tattoo sensor technology to measure and record heart rate and…
AI / Bridging the Innovation Gap
Professor Jackie Hunter looks at why the pharmaceutical industry has been so slow to adopt artificial…
Austria: Orchestrating Innovation
Austria has long been merely a cog in the wheel of global R&D, lying in the shadows of neighboring research…
Turkey Turns Towards Pharmaceutical Innovation
In the coming years, Turkey plans to prioritize R&D initiatives, health studies and medical innovation:…
Market Access in Switzerland / Reimbursement Delays for 76% of New Products Undermining Innovation Reputation
Switzerland, rightly regarded as one of the world’s most innovative nations, risks damaging its reputation if…
65 Years of Promoting Pharmaceutical Innovation in Mexico
In order to mark its 65th anniversary, the Mexican Association of Pharmaceutical Research Industries (AMIIF)…
Australia – Innovation Down Under
Australia, the “land down under” to many Westerners, is sometimes left at just that — out of sight,…
European Cancer Forum 2020 / Belgian MoH Maggie De Block Delivers Strong Message on Access to Innovation
The second edition of the European Cancer Forum was held in Brussels, Belgium on Tuesday, 29 January 2020. Hosted…
Regulatory Science Struggling to Keep Pace with Innovation
While drug developers, healthcare practitioners and patients all rejoice at the advent of a golden age of…
Latvia / Striving to Catch Up to its Neighbours on Innovation Access
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
CEE / The Czech Republic’s Long Road Towards Innovation
The Czech Republic is aiming to carve out a space for itself among Europe’s most innovative countries by 2030 as…
Singapore / Building a Globally Competitive Innovation Ecosystem
Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest…
Vaccines / Market Model Innovation
While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the…
Switzerland / Ticino Looking to Innovative Future With Big New Investment
The small Italian-speaking Canton of Ticino, nestled away in Southern Switzerland, is fast developing its…
Switzerland: A Hotbed of Innovation
Switzerland’s especially fine reputation for research impact and innovation generation is attracting a host of…
Access / UAE: A World Leader for Early Access to Innovation
The UAE ranks as a world leader in rapid drug approvals with its fast-track registration system that accelerates…
Kobe: A Center of Excellence for Biomedical Innovation
Kenichi Tamiya, director for Biomedical Policy at the Kobe City Government and managing director of the Kobe…
Company Spotlight / JLABS @ Shanghai
Johnson & Johnson’s network of healthcare innovation incubators, JLABS, opened its doors in Shanghai in June…
Promoting Japanese Bio-industry Innovation
Prof. Yoshiaki Tsukamoto, executive director of the Japan Bioindustry Association (JBA), talked exclusively to…
Market Access / A New Era in the Czech Republic?
Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most…
A Framework for R&D Investment and Innovation in Turkey
Although the Turkish pharmaceutical market has grown significantly in recent years R&D investment remains…
The Long Read / Sweden: An Innovation Nation
Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10 million and marginal positioning on the…
Korea: Prioritising AI in Healthcare Innovation
The South Korean government has designated the promotion of artificial intelligence (AI)-based drug development and…
USA / The Long Read: Innovation, Access & Affordability
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly…
San Diego / What it Takes to be a Successful Life Science Innovation Centre
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park highlights key takeaways from the BIOJapan 2020…